Dr. Johad Khoury is a physician-scientist specializing in internal medicine and pulmonary medicine. After earning his M.D. from the Technion School of Medicine in Israel, he completed his internship and residency at Rambam Health Care Campus, followed by a clinical fellowship in pulmonary diseases at Carmel Medical Center. He later became a senior physician at Carmel, where he established the first post-COVID clinic in northern Israel, and developed the pulmonary division at EMMS Nazareth Hospital.
Dr. Khoury joined the Yale School of Medicine in May 2021 as a postdoctoral associate in Dr. Naftali Kaminski’s lab. His research focuses on identifying novel pathways involved in idiopathic pulmonary fibrosis (IPF). Notably, he discovered the role of G-protein coupled receptor 87 (GPR87) in pulmonary fibrosis and received multiple awards for this work, including the Department of Defense Discovery Award, the Boehringer Ingelheim Discovery Award, and the ICLAF Abstract Award. His ongoing work explores the inhibition of pro-fibrotic pathways, including GPR87, as potential treatments for IPF.
In this webinar, Dr. Khoury will:
•Describe methods for inflating animal and human lung tissue to prepare for precision-cut lung slices (PCLS)
•Discuss approaches for fibrosis induction in ex vivo models
•Highlight how advanced technologies are integrated into PCLS-based research
•Present strategies for evaluating potential treatments for pulmonary fibrosis using PCLS
This session will provide valuable insights into how PCLS models can bridge basic and translational research in pulmonary fibrosis.